Free Trial

Cumberland Pharmaceuticals (CPIX) SEC Filings & 10K Form

Cumberland Pharmaceuticals logo
$3.47 +0.07 (+2.06%)
Closing price 04:00 PM Eastern
Extended Trading
$3.45 -0.02 (-0.58%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cumberland Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/11/2025
7:50 AM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
8:00 AM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
8:12 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
7:39 AM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
4:03 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2025
4:46 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:48 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:49 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2025
4:50 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:36 AM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:37 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:38 AM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:39 AM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:26 PM
Cumberland Pharmaceuticals (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G
04/28/2025
2:38 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
12:36 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
12:37 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
12:37 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
12:38 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:07 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:30 PM
Cumberland Pharmaceuticals (Filer)
Form ARS
03/18/2025
4:11 PM
Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:11 PM
Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:12 PM
Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:13 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:14 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:15 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:15 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:06 PM
Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:09 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:10 PM
Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Cumberland Pharmaceuticals (Filer)
Form DEF 14A
03/10/2025
4:01 PM
Cumberland Pharmaceuticals (Filer)
Form DEFA14A
03/07/2025
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
4:26 PM
Cumberland Pharmaceuticals (Subject)
KAZIMI A J (Filed by)
Form SCHEDULE 13G
02/04/2025
3:37 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
3:38 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4/A
01/30/2025
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4/A
01/30/2025
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4/A
01/30/2025
3:40 PM
Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4/A
12/30/2024
6:41 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel

Watch the National Emergency broadcast here
12/30/2024
6:44 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:45 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:47 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:02 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:03 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:04 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:05 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:09 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
4:12 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:38 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:06 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:07 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:08 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:31 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
9:42 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:29 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:40 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:42 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CPIX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners